CAS: 90825-43-7 - L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, sodium salt (1:1)

Formule : C₅₉H₁₀₉N₆O₁₉P·Na

InChI : InChI=1S/C59H109N6O19P.Na/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-33-52(71)80-41-47(84-53(72)34-32-30-28-26-24-22-20-18-16-14-12-10-8-2)42-82-85(78,79)81-38-37-61-57(75)43(3)62-51(70)36-35-48(56(60)74)65-58(76)44(4)63-59(77)45(5)83-55(54(73)50(69)40-67)49(39-66)64-46(6)68;/h39,43-45,47-50,54-55,67,69,73H,7-38,40-42H2,1-6H3,(H2,60,74)(H,61,75)(H,62,70)(H,63,77)(H,64,68)(H,65,76)(H,78,79);/t43-,44-,45+,47+,48+,49-,50+,54+,55+;/m0./s1

Code InChI : InChIKey=DATHREMRBCGNHW-XNLRRNFISA-N

SMILES : [Na].O=CC(NC(=O)C)C(OC(C(=O)NC(C(=O)NC(C(=O)N)CCC(=O)NC(C(=O)NCCOP(=O)(O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC)C)C)C)C(O)C(O)CO

Synonymes :

• L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, sodium salt (1:1)
• Mepact
• L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, monosodium salt, (R)-
• CGP 19835A
• L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, monosodium salt

Mifamurtide sodium

CAS : 90825-43-7

Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children …

• Formule : C₅₉H₁₀₈N₆NaO₁₉P
• Degré de pureté : 98%
• Couleur et forme : Solid
• Masse moléculaire : 1259.48

Mifamurtide sodium

CAS : 90825-43-7

Mifamurtide sodium is a peptide that has been shown to activate the receptor for nerve …

• Formule : C₅₉H₁₀₈N₆NaO₁₉P
• Degré de pureté : Min. 95%
• Masse moléculaire : 1,259.5 g/mol